|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Aedes_aegypti
gptkb:DENV-1
gptkb:DENV-2
gptkb:DENV-3
gptkb:DENV-4
gptkb:Flaviviridae
gptkb:Aedes_mosquitoes
|
|
gptkbp:associated_with
|
climate change
urbanization
|
|
gptkbp:caused_by
|
gptkb:healthcare_organization
|
|
gptkbp:communication
|
gptkb:Aedes_mosquitoes
|
|
gptkbp:community_involvement
|
crucial for control efforts
|
|
gptkbp:complications
|
gptkb:Dengue_hemorrhagic_fever
gptkb:Dengue_shock_syndrome
|
|
gptkbp:coordinates
|
gptkb:Aedes_aegypti
gptkb:Aedes_albopictus
environmental management
larviciding
insecticide spraying
|
|
gptkbp:distribution
|
increasing
|
|
gptkbp:end_of_life
|
higher in severe cases
low in non-severe cases
|
|
gptkbp:global_presence
|
estimated 390 million infections annually
|
|
gptkbp:healthcare
|
gptkb:battle
key to prevention
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dengue fever
|
|
gptkbp:incubation_period
|
4 to 10 days
|
|
gptkbp:is_protected_by
|
vaccination
mosquito control
|
|
gptkbp:is_recognized_by
|
1950s
|
|
gptkbp:is_vulnerable_to
|
gptkb:Qdenga
gptkb:TAK-003
gptkb:Dengvaxia
|
|
gptkbp:native_to
|
gptkb:Caribbean
gptkb:Latin_America
gptkb:Southeast_Asia
gptkb:Pacific_Islands
|
|
gptkbp:public_awareness
|
important for prevention
|
|
gptkbp:research
|
ongoing
|
|
gptkbp:research_focus
|
vaccine development
disease surveillance
vector control strategies
|
|
gptkbp:risk_factor
|
urban areas
tropical and subtropical climates
|
|
gptkbp:scientific_classification
|
Category A
|
|
gptkbp:seasonal_activities
|
rainy season
|
|
gptkbp:social_responsibility
|
blood test
PCR test
N S1 antigen test
common in endemic regions
requires rapid action
|
|
gptkbp:symptoms
|
rest
pain relief
rash
varies by individual
high fever
joint and muscle pain
mild bleeding
pain behind the eyes
2 to 7 days
severe headache
|
|
gptkbp:treatment
|
hydration
supportive care
pain relievers
avoidance of aspirin
|